MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing (vol 37, pg 2008, 2007)

Eitemau Tebyg

• MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.
  gan: Held, G, et al.
  Cyhoeddwyd: (2007)
• Erratum: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing (European Journal of Immunology (2007) vol. 37 (7) 10.1002/eji.200636545)
  gan: Held, G, et al.
  Cyhoeddwyd: (2008)
• Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
  gan: Maczek, C, et al.
  Cyhoeddwyd: (2005)
• Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC
  gan: Hoerter, John A. H., et al.
  Cyhoeddwyd: (2014)
• Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
  gan: Valmori, D, et al.
  Cyhoeddwyd: (2000)